Question 1
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient with
... [Show More] psychosis and aggression?
Selected Answer:
A.
There is too high a risk of serious adverse side effects.
• Question 2
1 out of 1 points
A 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation and aggressive behavior. The PMHNP determines which of the following to be the best treatment option?
Selected Answer:
D.
Citalopram (Celexa) or Escitalopram (Lexapro)
• Question 3
1 out of 1 points
A group of nursing students seeks further clarification from the PMHNP on how cholinesterase inhibitors are beneficial for Alzheimer’s disease patients. What is the appropriate response?
Selected Answer:
D.
Both “A” & “C.”
• Question 4
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most appropriate for which patient with ADHD?
Selected Answer:
A.
8-year-old patient
Question 1
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient with psychosis and aggression?
Selected Answer:
A.
There is too high a risk of serious adverse side effects.
• Question 2
1 out of 1 points
A 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation and aggressive behavior. The PMHNP determines which of the following to be the best treatment option?
Selected Answer:
D.
Citalopram (Celexa) or Escitalopram (Lexapro)
• Question 3
1 out of 1 points
A group of nursing students seeks further clarification from the PMHNP on how cholinesterase inhibitors are beneficial for Alzheimer’s disease patients. What is the appropriate response?
Selected Answer:
D.
Both “A” & “C.”
• Question 4
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most appropriate for which patient with ADHD?
Selected Answer:
A.
8-year-old patient [Show Less]